fda compounded glp‑1 restrictions

FDA moves to restrict compounded versions of popular GLP-1 weight loss drugs — Photo by Tima Miroshnichenko on Pexels

7 Hidden Costs In Prescription Weight loss Exposed

7 Hidden Costs In Prescription Weight loss Exposed The FDA’s new compounding rule could raise your weight-loss drug copay by as much as 30%. Patients and providers alike are scrambling to understand how the agency’s April 2026 clarification on 503B bulk drug listings will ripple through pharmacies, insurers,